Isolated, PSMA-negative penile metastasis from castration resistant prostate adenocarcinoma, identified by FDG-PET
Penile metastases are a rare entity and are associated with widespread metastatic disease. It is associated with significant morbidity with a poor prognosis. There have been few case reports about metastatic prostate adenocarcinoma to the penis. Diagnosis is often clinical, however, the use of PSMA...
Main Authors: | Matthew Chau, Nicole Swarbrick, Sunny Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Urology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214442022003126 |
Similar Items
-
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?
by: Luca Urso, et al.
Published: (2023-11-01) -
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT
by: Annalice Gandini, et al.
Published: (2023-08-01) -
Clinical Applications of PSMA PET Examination in Patients with Prostate Cancer
by: Sazan Rasul, et al.
Published: (2022-08-01) -
Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer
by: Matthew Alberto, et al.
Published: (2022-08-01) -
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer
by: Adam M. Kase, et al.
Published: (2022-03-01)